These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21813657)

  • 1. Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine.
    Chirkova TV; Naykhin AN; Petukhova GD; Korenkov DA; Donina SA; Mironov AN; Rudenko LG
    Clin Vaccine Immunol; 2011 Oct; 18(10):1710-8. PubMed ID: 21813657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).
    Rudenko L; Desheva J; Korovkin S; Mironov A; Rekstin A; Grigorieva E; Donina S; Gambaryan A; Katlinsky A
    Influenza Other Respir Viruses; 2008 Nov; 2(6):203-9. PubMed ID: 19453396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the anti-neuraminidase antibodies in clinical trials of the live influenza vaccine of the A(H5N2) subtype].
    Smolonogina TA; Desheva IuA; Rekstin AR; Mironov AN; Rudenko LG
    Vopr Virusol; 2013; 58(6):31-5. PubMed ID: 24772644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stimulation of homo- and heterologic T-cell immunological memory in volunteers inoculated with live influenza A (H5N2) reassortant vaccine].
    Naĭkhin AN; Chirkova TV; Petukhova GD; Koren'kov DA; Donina SA; Rudenko LG
    Vopr Virusol; 2012; 57(1):38-42. PubMed ID: 22624472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross- immunity of a H9N2 live attenuated influenza vaccine against H5N2 highly pathogenic avian influenza virus in chickens.
    Wang M; Wei Y; Pu J; Bing G; Sun Y; Sun H; Wei F; Liu J
    Vet Microbiol; 2018 Jul; 220():57-66. PubMed ID: 29885802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of clinical trials on reactogenicity, safety, and immunogenicity of influenza allantoic intranasal live vaccine "Ultragrivac" (type A/H5N2)].
    Mazurkova NA; Ryndiuk NN; Shishkina LN; Ternovoĭ VA; Tumanov IuV; Bulychev LE; Skarnovich MO; Kabanov AS; Panchenko SG; Aleĭnikov RP; Il'ina TN; Kuzubov VI; Mel'nikov SIa; Mironov AN; Korovkin SA; Sergeev AN; Drozdov IG
    Vestn Ross Akad Med Nauk; 2010; (3):15-20. PubMed ID: 20422755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
    Kiseleva I; Dubrovina I; Fedorova E; Larionova N; Isakova-Sivak I; Bazhenova E; Pisareva M; Kuznetsova V; Flores J; Rudenko L
    Vaccine; 2015 Dec; 33(49):7008-14. PubMed ID: 26432909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B- and T-cell memory elicited by a seasonal live attenuated reassortant influenza vaccine: assessment of local antibody avidity and virus-specific memory T-cells using trogocytosis-based method.
    Petukhova G; Korenkov D; Chirkova T; Donina S; Rudenko L; Naykhin A
    Influenza Other Respir Viruses; 2012 Mar; 6(2):119-26. PubMed ID: 21819548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Estimation of human and animal immunological memory by testing the trogocytosis of virus-specific T lymphocytes].
    Naĭkhin AN; Koren'kov DA; Chirkova TV; Petukhova GD; Donina SA; Rudenko LG
    Vopr Virusol; 2011; 56(5):15-21. PubMed ID: 22171472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The inoculative properties of cold-adapted reassortant A(H5N2) influenza strain during intranasal administration to mice].
    Desheva IuA; Lu Kh; Rekstin AR; Kats DM; Rudenko LG; Klimov AI
    Vopr Virusol; 2007; 52(4):27-30. PubMed ID: 17722607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double-blind phase I study.
    Rudenko L; Kiseleva I; Stukova M; Erofeeva M; Naykhin A; Donina S; Larionova N; Pisareva M; Krivitskaya V; Flores J;
    Vaccine; 2015 Sep; 33(39):5110-7. PubMed ID: 26296497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A live attenuated H5N2 prime- inactivated H5N1 boost vaccination induces influenza virus hemagglutinin stalk specific antibody responses.
    Kongchanagul A; Samnuan K; Wirachwong P; Surichan S; Puthavathana P; Pitisuttithum P; Boonnak K
    Vaccine; 2020 Jan; 38(4):852-858. PubMed ID: 31708176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults.
    Talaat KR; Karron RA; Liang PH; McMahon BA; Luke CJ; Thumar B; Chen GL; Min JY; Lamirande EW; Jin H; Coelingh KL; Kemble GW; Subbarao K
    Influenza Other Respir Viruses; 2013 Jan; 7(1):66-73. PubMed ID: 22417012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo-controlled, randomized double-blind phase I study of live attenuated H7N3 influenza vaccine.
    Rudenko L; Kiseleva I; Naykhin AN; Erofeeva M; Stukova M; Donina S; Petukhova G; Pisareva M; Krivitskaya V; Grudinin M; Buzitskaya Z; Isakova-Sivak I; Kuznetsova S; Larionova N; Desheva J; Dubrovina I; Nikiforova A; Victor JC; Neuzil K; Flores J; Tsvetnitsky V; Kiselev O
    PLoS One; 2014; 9(2):e87962. PubMed ID: 24533064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of American-Lineage Influenza H5N2 Reassortant Vaccine Viruses for Pandemic Preparedness.
    Chen PL; Hu AY; Lin CY; Weng TC; Lai CC; Tseng YF; Cheng MC; Chia MY; Lin WC; Yeh CT; Su IJ; Lee MS
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31212631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
    Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
    Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline levels of influenza-specific CD4 memory T-cells affect T-cell responses to influenza vaccines.
    He XS; Holmes TH; Sasaki S; Jaimes MC; Kemble GW; Dekker CL; Arvin AM; Greenberg HB
    PLoS One; 2008 Jul; 3(7):e2574. PubMed ID: 18596908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
    Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses.
    Kandeil A; Moatasim Y; Gomaa MR; Shehata MM; El-Shesheny R; Barakat A; Webby RJ; Ali MA; Kayali G
    Vaccine; 2016 Jan; 34(2):218-224. PubMed ID: 26620838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses.
    Matyushenko V; Kotomina T; Kudryavtsev I; Mezhenskaya D; Prokopenko P; Matushkina A; Sivak K; Muzhikyan A; Rudenko L; Isakova-Sivak I
    Antiviral Res; 2020 Oct; 182():104864. PubMed ID: 32585323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.